Jersey City Local News
3D Metrology Market Global Key Manufacturers Analysis for 2017-2022 | ReportsnReports
06 12 2017
PUNE, India, December 6, 2017 --
3D Metrology Market manufacturers those involve in this research are Hexagon, Zeiss, FARO, Renishaw Plc, Nikon Metrology, GOM, Mitutoyo, Keyence, Perceptron, 3D Digital Corp, Wenzel and Zygo.
Global 3D Metrology Market 2017 Research Report initially provides a basic overview of the industry that covers definition, applications and manufacturing technology, post which the report explores into the international players in the market.
Complete report on 3D Metrology market spread across 112 pages providing 12 company profiles and 193 tables and figures is available at http://www.reportsnreports.com/reports/1057538-global-3d-metrology-market-research-report-2017.html .
Market Segment by Regions, this report splits Global into several key Region, with production, consumption, revenue, market share and growth rate of 3D Metrology in these regions, from 2011 to 2022 (forecast), like North America, China, Europe, Japan, India, Southeast Asia split by product...
Belkin Rolls Out Next Iteration Of Advanced Screen Protection
06 12 2017
LOS ANGELES, Dec. 6, 2017 -- Belkin®, market leader in mobile accessories and screen care, today introduced its comprehensive portfolio of curved screen protection for iPhone, Apple Watch and Samsung devices. Engineered to accommodate the curved edges of these devices, the new line provides screens with superior durability, resilience and seamless coverage. The comprehensive coverage significantly reduces device vulnerability to scratches, scuffs and damages.
Belkin's TrueClear Pro 2.0 screen protection application system is a unique, first-of-its-kind system designed to apply Belkin screen protectors to devices with unparalleled accuracy.
"If you're going to spend hundreds of dollars on a smart device, it's smart to protect your investment. People tend to take protection and insurance for granted, not giving it a thought until something goes wrong. We recommend thinking about it before something happens," said Eric Co, director of product management,...
BFFT: German Engineering for the US
06 12 2017
BELMONT, California, December 6, 2017 --
When it comes to the mobility of the future, BFFT has been a trend-setting player on the German premium car market for many years. Especially for the VW Group - and in particular for luxury brand Audi - the electronics specialist from Germany is known for being a benchmark in the areas of driver assistance systems, digitization and electrification.
BFFT-of-America-CEO Angelika Eitermoser on location at the L.A. Auto Show. (Source: BFFT) (PRNewsfoto/BFFT Fahrzeugtechnik mbH)
Driver assistance system testing in virtual test lab. (Source: BFFT) (PRNewsfoto/BFFT Fahrzeugtechnik mbH)
(Photo: http://mma.prnewswire.com/media/616332/BFFT_Fahrzeugtechnik_CEO_Angelika_Eitermoser.jpg )
(Photo: http://mma.prnewswire.com/media/616329/BFFT_Fahrzeugtechnik_mbH_LA_Auto_Show.jpg )
With the manpower of over 800 German experts behind it, BFFT is also conquering California. Since 2013, around 30...
NATIXIS :Natixis and ODDO BHF are considering a long-term partnership aimed at creating a leading equity-market player in continental Europe
06 12 2017
PRESS RELEASE Paris, December 6, 2017Natixis and ODDO BHF are considering a long-term partnership aimed at creating a leading equity-market player in continental EuropeNatixis and ODDO BHF are considering a long-term partnership aimed at creating a major player on equity brokerage and equity capital markets (ECM) in Continental Europe. The combination of the two partners' equity research and sales teams serving corporate clients and investors, the strength...
Boston Therapeutics, Inc. Announces New Dosing Regimen for BTI320
06 12 2017
LAWRENCE, Mass., Dec. 06, 2017 -- Boston Therapeutics, Inc is pleased to announce that effective sugar reduction with the investigative BTI320 formulation requires only one tablet. Findings were confirmed by the most recent proof-of-concept study conducted in high-risk Chinese subjects with pre-diabetes. A formulation, in the form of a dietary supplement, is currently available as SUGARDOWN®, SUGARBLOCK and SUGARBALANCE in USA and Asia. Results of this study (Clinicaltrials.gov) were presented at the 77th American Diabetes Association (ADA) conference in June 2017 and exhibited that one tablet was effective in lowering the one and two-hour postprandial glucose levels in pre-diabetic subjects.CEO, Carl W Rausch describes the significance of this change, “Moving from the two-tablet initial consumption to the single tablet has a two-fold benefit. It will improve compliance and broaden a positive outcome experience. It will also enhance convenience and lower costs to individuals, immediately...
Immunomedics Announces Updated Results With Sacituzumab Govitecan (IMMU-132) In Patients With Relapsed Or Refractory Metastatic Triple-Negative Breast Cancer (mTNBC)
06 12 2017
Objective Response Rate (ORR) = 31% (Centrally Reviewed); 34% (Locally Assessed)Median Duration of Response (DOR) = 9.1 Months (Centrally Reviewed); 7.6 Months (Locally Assessed)Clinical Benefit Rate at 6 Months = 45% (Locally Assessed)Submission of Biologics License Application (BLA) for Accelerated Approval of Sacituzumab Govitecan as Third-Line Treatment for mTNBC Remains on Track for First Quarter of 2018SAN ANTONIO, Dec. 06, 2017 -- Immunomedics, Inc. (NASDAQ:IMMU) (“Immunomedics” or the “Company”) today announced that a blinded, independent review by an adjudication team of radiologists has determined an ORR of 31%, including six complete responses (CRs) and 28 partial responses (PRs), in 110 patients with mTNBC after receiving treatment with sacituzumab govitecan, the Company’s lead investigational antibody-drug conjugate (ADC), in a Phase 2 study. The independent centrally-reviewed (ICR) median DOR was 9.1 months. These efficacy data are summarized in the table below.*...
GUERBET : Gadolinium-based contrast agents: update on MHLW decision in Japan
06 12 2017
Villepinte (France), December 6, 2017 (6pm CET) - Guerbet (FR0000032526 GBT), a global specialist in contrast agents and solutions for medical imaging, takes note of the decision issued on November 28 by the Japanese Ministry of Health, Labour and Welfare (MHLW), regarding the mandatory revision of the precautions section in the package insert of gadolinium-based contrast agents (GBCAs), with immediate effect.In parallel to the European Commission's decision to suspend the use of non-specific linear gadolinium agents in body scans, the MHLW has decided to restrict the use of non-specific linear GBCAs only in cases where there is no alternative, based on the "higher Gadolinium accumulation in brain reported with these linear agents".For all GBCAs, "the necessity of MRI scan using gadolinium-based contrast agents should be determined carefully" as stated in the Japanese new package insert.Magnetic resonance imaging (MRI) is a widely used diagnostic procedure which is critical...
Intellinetics Completes Convertible Debt Financing and Retires Senior Debt at a Discount
06 12 2017
COLUMBUS, OH, Dec. 06, 2017 -- Intellinetics, Inc. (OTCQB: INLX), a cloud-based content services provider, announced it has closed the final tranche of a convertible promissory notes financing and raised a total of $2,000,000 of new money.As part of this financing, the senior secured debt with the Development Services Agency of the State of Ohio (“Development Authority”) was retired on November 17, 2017, with a cash payment of $525,000. As agreed with the Development Authority, this cash payment satisfied in full the obligations under the existing loans, which totaled $943,216, including aggregate outstanding principal, interest, and accrued fees. Additionally, the funds raised from the offering will be used for operations and investments in a revamped marketing strategy, with the foundations already laid following the September 2017 start of Intellinetics’ new CEO.James F. DeSocio, President & CEO of Intellinetics, stated, “It’s great that we reached an...
Live Traffic in Jersey City, NJ